CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $872,783
- in 6 filings, $873K under 10b5-1 plans
Net −$872,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Taylor Brenton −$246K EVP, Operations & R&D sold 9% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Zurbay Donald Director | Grant or award | +28,261 | 193,613 | ||
| 2025-06-05 | Zurbay Donald Director | Grant or award | +30,952 | 165,352 | ||
| 2024-06-06 | Zurbay Donald Director | Grant or award | +17,366 | 117,460 | ||
| 2023-06-08 | Zurbay Donald Director | Grant or award | +11,940 | 74,440 | ||
| 2023-06-08 | Zurbay Donald Director | Grant or award | +15,094 | 74,440 | ||
| 2022-06-08 | Zurbay Donald Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 |
Page 1 of 1 · 6 trades